AIP and growth hormone-producing pituitary gland neoplasm: AIP mutations were found in 20.5% of pediatric patients, 13.3% of sporadic somatotropinoma patients, 11.5% of prolactinoma patients, and 1/16 patients with non-functional pituitary adenoma [47].